Synteract and Harrison Clinical Research Close Deal

Synteract, a full-service contract research organization has completed its acquisition of Harrison Clinical Research to form a new multinational business – SynteractHCR. Synteract is a portfolio company of San Francisco-based Gryphon Investors.

4 March 2013•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles